These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 37759937)
1. Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation. Li Y; Srinath A; Alcazar-Felix RJ; Hage S; Bindal A; Lightle R; Shenkar R; Shi C; Girard R; Awad IA Brain Sci; 2023 Sep; 13(9):. PubMed ID: 37759937 [TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin. Retta SF; Glading AJ Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):254-270. PubMed ID: 27639680 [TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation Plays a Critical Role in Cerebral Cavernous Malformation Disease. Lai CC; Nelsen B; Frias-Anaya E; Gallego-Gutierrez H; Orecchioni M; Herrera V; Ortiz E; Sun H; Mesarwi OA; Ley K; Gongol B; Lopez-Ramirez MA Circ Res; 2022 Nov; 131(11):909-925. PubMed ID: 36285625 [TBL] [Abstract][Full Text] [Related]
4. From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease. Retta SF; Perrelli A; Trabalzini L; Finetti F Methods Mol Biol; 2020; 2152():3-25. PubMed ID: 32524540 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease. Perrelli A; Retta SF Free Radic Biol Med; 2021 Aug; 172():403-417. PubMed ID: 34175437 [TBL] [Abstract][Full Text] [Related]
6. Transcriptomic signatures of individual cell types in cerebral cavernous malformation. Li Y; Girard R; Srinath A; Cruz DV; Ciszewski C; Chen C; Lightle R; Romanos S; Sone JY; Moore T; DeBiasse D; Stadnik A; Lee JJ; Shenkar R; Koskimäki J; Lopez-Ramirez MA; Marchuk DA; Ginsberg MH; Kahn ML; Shi C; Awad IA Cell Commun Signal; 2024 Jan; 22(1):23. PubMed ID: 38195510 [TBL] [Abstract][Full Text] [Related]
7. Common transcriptome, plasma molecules, and imaging signatures in the aging brain and a Mendelian neurovascular disease, cerebral cavernous malformation. Koskimäki J; Polster SP; Li Y; Romanos S; Srinath A; Zhang D; Carrión-Penagos J; Lightle R; Moore T; Lyne SB; Stadnik A; Piedad K; Cao Y; Shenkar R; Dimov AV; Hobson N; Christoforidis GA; Carroll T; Girard R; Awad IA Geroscience; 2020 Oct; 42(5):1351-1363. PubMed ID: 32556941 [TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of familial and sporadic pediatric cerebral cavernous malformations and outcomes. Jaman E; Abdallah HM; Zhang X; Greene S J Neurosurg Pediatr; 2023 Oct; 32(4):506-513. PubMed ID: 37503918 [TBL] [Abstract][Full Text] [Related]
9. Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies. Marchi S; Trapani E; Corricelli M; Goitre L; Pinton P; Retta SF Rare Dis; 2016; 4(1):e1142640. PubMed ID: 27141412 [TBL] [Abstract][Full Text] [Related]
10. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH). Girard R; Li Y; Stadnik A; Shenkar R; Hobson N; Romanos S; Srinath A; Moore T; Lightle R; Shkoukani A; Akers A; Carroll T; Christoforidis GA; Koenig JI; Lee C; Piedad K; Greenberg SM; Kim H; Flemming KD; Ji Y; Awad IA Neurosurgery; 2021 Feb; 88(3):686-697. PubMed ID: 33469662 [TBL] [Abstract][Full Text] [Related]
11. Intracranial Hemorrhage Rate and Lesion Burden in Patients With Familial Cerebral Cavernous Malformation. Weinsheimer S; Nelson J; Abla AA; Ko NU; Tsang C; Okoye O; Zabramski JM; Akers A; Zafar A; Mabray MC; Hart BL; Morrison L; McCulloch CE; Kim H; J Am Heart Assoc; 2023 Feb; 12(3):e027572. PubMed ID: 36695309 [TBL] [Abstract][Full Text] [Related]